CCCC vs ORCL · rev $35.6M vs P/E 31, rev $67.36B
C4 Therapeutics Inc (CCCC) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
CCCC currently screens at market cap $425.7M. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the CCCC and ORCL stock pages for the full models.
Not investment advice.